Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Discover various ways to save and invest in 2023 that will help you grow your finances and achieve your financial goals.
28,655 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Broadcom reports AI-related revenue more than doubles in the latest quarter, but the stock trades flat as investors w...
Tesla stock slides as delivery fears collide with SpaceX IPO chatter and a Cybercab roadmap, leaving investors weighi...
U.S. credit card debt climbed to a record $1.28 trillion in late 2025, even as a booming influencer economy promotes ...
Markets moved to risk-off trading after Xi warned of a possible clash with the United States over Taiwan, hours befor...
NextEra Energy announces a $67 billion all-stock deal to buy Dominion Energy, a move that could kick off a broader wa...
Syndicate Labs, a16z-backed, is closing its development arm after five years of building on-chain tooling, blaming a ...
NVIDIA's earnings call surfaced a link between Meta’s AI model and stronger ad performance, igniting questions for ad...
As lawmakers push a sweeping crypto regulation bill, the former president's outspoken support for digital assets is c...
A former minutes correspondent doesn't express confidence in the long-term future of 60 Minutes as advertisers shift ...
Tech stocks staged a partial recovery on Monday as the Nasdaq rebounded, but higher oil prices and stubborn yields ke...
Io.Net introduces an incentive framework designed to align rewards with real network contribution, aiming to stabiliz...